56 results
Keyword Abba Remove keyword
-
List item
National expert: Luca Massacesi, Italian Medicines Agency (updated)
- Declaration of interests - 84.23 KB | PDF
- Curriculum Vitae - 55.57 KB | PDF
1635-1641. 3. Massacesi L., Abbamondi A.L., Sarlo F. and Amaducci … 57:166-169. 4. Massacesi L., Abbamondi A.L., Giorgi C., Sarlo F … 80:55-64. 5. Massacesi L., Abbamondi A.L., Raimondi L., Giorgi … -
List item
National expert: Celine Chu, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 18.4 KB | PDF
INFORMATION Expertise Publications 1-Chu C, Abbara C, Noel-Hudson MS, Thomas-Bourgneuf … Aug;27(4):434-42. 5-Chu C, Abbara C, Tandia M, Polrot M, Gonin … -
List item
Human medicine European public assessment report (EPAR): Arixtra
fondaparinux sodium, Venous Thrombosis; Pulmonary Embolism; Myocardial Infarction; Angina, Unstable
Date of authorisation: 20/03/2002, Revision: 34, Authorised, Last updated: 11/11/2022 -
List item
National expert: Jens-Uwe Bleich, Norwegian Medicines Agency (updated)
- Declaration of interests - 80.05 KB | PDF
- Curriculum Vitae - 17.39 KB | PDF
Charakterisierung biologisch abbaubarer Mikropartikel mit dem Aerosol Solvent … -
List item
Veterinary medicine European public assessment report (EPAR): Rheumocam
meloxicam, Dogs; Horses; Cats; Cattle; Pigs
Date of authorisation: 10/01/2008,
, Revision: 17, Authorised, Last updated: 18/11/2021
-
List item
Human medicine European public assessment report (EPAR): Tezspire
tezepelumab, Asthma
Date of authorisation: 19/09/2022,
, Revision: 1, Authorised, Last updated: 09/11/2022
-
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,
, , Revision: 25, Authorised, Last updated: 30/11/2022
-
List item
National expert: Flora Peyvandi, European Medicines Agency (updated)
- Declaration of interests - 85.75 KB | PDF
- Curriculum Vitae - 147.78 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Rapiscan
regadenoson, Myocardial Perfusion Imaging
Date of authorisation: 06/09/2010, Revision: 14, Authorised, Last updated: 30/06/2022 -
List item
Human medicine European public assessment report (EPAR): Savene
dexrazoxane hydrochloride, Extravasation of Diagnostic and Therapeutic Materials
Date of authorisation: 27/07/2006, Revision: 14, Authorised, Last updated: 08/10/2019 -
List item
Human medicine European public assessment report (EPAR): Cervarix
human papillomavirus1 type 16 L1 protein, human papillomavirus type 18 L1 protein, Papillomavirus Infections; Uterine Cervical Dysplasia; Immunization
Date of authorisation: 20/09/2007, Revision: 38, Authorised, Last updated: 05/05/2022 -
List item
National expert: Nils Lilienthal, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 19.78 KB | PDF
Lilienthal N, Nicco C, Scherer C, Abbas M, Zada AA, Coriat R, Burkholz … -
List item
National expert: Concetta Quintarelli, Italian Medicines Agency (updated)
- Declaration of interests - 80.39 KB | PDF
- Curriculum Vitae - 27.1 KB | PDF
I, Orlando D, Guercio M, Abbaszadeh Z, Sinibaldi M, Di Cecca … I, Sinibaldi M, Po A, Caruana I, Abballe L, Carai A, Moseley A, Hagedoorn … -
List item
National expert: Alessandra Spagnoli, Italian Medicines Agency (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 32.51 KB | PDF
Persichetti, M., Mischitelli, M., Abbatecola, A., Di Martino, M., Lai, Q.,Carnevale … -
List item
National expert: Antonio Cherubini, Italian Medicines Agency (updated)
- Declaration of interests - 80.63 KB | PDF
- Curriculum Vitae - 42.84 KB | PDF
-
List item
National expert: Renato Bassan, European Medicines Agency (updated)
- Declaration of interests - 80.93 KB | PDF
- Curriculum Vitae - 57.45 KB | PDF
-
List item
National expert: Jacob Hendrik van Dieen, European Medicines Agency (updated)
- Declaration of interests - 79.82 KB | PDF
- Curriculum Vitae - 118.24 KB | PDF
-
List item
National expert: Anthony Serracino-Inglott, Medicines Authority (updated)
- Declaration of interests - 80.64 KB | PDF
- Curriculum Vitae - 101.75 KB | PDF
-
List item
National expert: Jose Manuel Zubeldia, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 24.34 KB | PDF
trial. Hourihane JO, Beyer K, Abbas A, Fernandez-Rivas M, Turner … -
List item
Withdrawn application: Tibsovo
ivosidenib, date of withdrawal: 13/10/2020, Initial authorisation, Last updated: 16/04/2021 -
List item
Withdrawn application: Blectifor
caffeine citrate, date of withdrawal: 09/03/2017, Initial authorisation, Last updated: 16/05/2017 -
List item
National expert: Marco Massari, Italian Medicines Agency (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 29.49 KB | PDF
Ingrasciotta Y, Ientile V, L'Abbate L, Foti SS, Belleudi V, Poggi … -
List item
National expert: Nadine Petitpain, Ministry for Health (updated)
- Declaration of interests - 81.19 KB | PDF
- Curriculum Vitae - 28.16 KB | PDF
Fourage C, Macro M, Olivier-Abbal P, Fleck C, Mouchel C, Gavard M … -
List item
National expert: Jan Welink, Medicines Evaluation Board (updated)
- Declaration of interests - 79.86 KB | PDF
- Curriculum Vitae - 29.96 KB | PDF
-
List item
National expert: Giancarlo Zito, Italian Medicines Agency (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 30.08 KB | PDF
C, Bertoli M, Gianni E, L'Abbate T, Trombetta E, Porcaro C …